145122-59-4

Upstream product

• 623-33-6 glycine ethyl ester hydrochloride 
• 145122-58-3 1-Benzyloxycarbonylamino-cyclopropanecarboxylic acid 2,5-dioxo-pyrrolidin-1-yl ester 
• 13139-17-8 N-(Benzyloxycarbonyloxy)succinimide 
• 84677-06-5 (benzyloxycarbonylamino)cyclopropanecarboxylic acid 

Downstream Products

• 145256-97-9 1-(2,4-difluorophenyl)-6-fluoro-7-(4,7-diazaspiro<2,5>octan-7-yl)-1,4-dihydro-4-oxo<1,8>naphthyridine-3-carboxylic acid trifluoroacetic acid salt 
• 145122-69-6 ethyl 1-(2,4-difluorophenyl)-6-fluoro-7-(4,7-diazaspiro<2,5>octan-7-yl)-1,4-dihydro-4-oxo<1,8>naphthyridine-3-carboxylate 
• 145122-56-1 4,7-diazaspiro<2,5>octane dihydrochloride 
• 129306-17-8 4,7-diazaspiro[2.5]octane-5,8-dione 

Relevant academic research and scientific papers

FIVE-MEMBERED HETEROCYCLIC DERIVATIVE

The present invention relates to a compound represented by formula (I): a salt of the compound, or a solvate of the compound or the salt; a drug containing any of the compounds, the salts, and the solvates; a preventive and/or therapeutic agent for an ischemic disease containing any of the compounds, the salts, and the solvates; and a platelet coagulation inhibitor containing any of the compounds, the salts, and the solvates. The compound of the present invention is useful as a strong platelet coagulation inhibitor without inhibiting COX-1 or COX-2.